Which MS drug strategy works best for older adults? new study aims to find out
NCT ID NCT07313462
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study looks at two ways to treat multiple sclerosis (MS) when it first appears after age 50. One approach starts with a moderate-strength drug and only switches to a stronger one if needed. The other starts with a strong drug right away. Researchers will compare how often relapses happen and what side effects occur, using data from 830 patients. The goal is to find out which strategy works better for this older age group.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
- Active substance
- disease-modifying therapies (moderate: teriflunomide, dimethyl fumarate, diroximel fumarate, glatiramer acetate, interferon beta, peginterferon; strong: fingolimod, ponesimod, natalizumab, rituximab, ocrelizumab, ofatumumab, cladribine)
- What this could lead to
- If successful, this study could help doctors choose the best first treatment for people diagnosed with MS after age 50, potentially reducing relapses and side effects.
- What could go wrong
- This is a retrospective study, not a controlled trial, so results may be influenced by factors other than the treatment. It cannot prove cause and effect, only suggest patterns.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for MULTIPLE SCLEROSIS, MS are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Centre d'Investigation Clinique - CHU de Strasbourg - France
RECRUITINGStrasbourg, 67091, France
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Hidden MS progression: can brain scans and blood tests predict it?
- Can a new MRI scan reveal the Brain's hidden repair process in MS?
- Can a single injection tame stubborn multiple sclerosis?
- Walking workouts may sharpen the MS brain — a trial puts it to the test
- Can a simple obstacle course reveal hidden links between fatigue and walking trouble in MS?
- Can sensing wrist position unlock better hand control in MS?